Those with episodic amnesia are not ‘stuck in time,’ says philosopher Carl Craver
It has generally been assumed that people with episodic amnesia experience time much differently than those with more typical memory function. However, recent research by Washington University philosopher Carl F. Craver, PhD, disputes this type of claim. “There are sets of claims that sound empirical, like ‘These people are stuck in time.’ But if you ask, ‘Have you actually tested what they know about time?’ the answer is no.”
Eghtesady named inaugural Emerson Chair in Pediatric Cardiothoracic Surgery
Pirooz Eghtesady, MD, PhD, has been named the first Emerson Chair in Pediatric Cardiothoracic Surgery at St. Louis Children’s Hospital and Washington University School of Medicine. He is a professor of surgery and of pediatrics and is chief of the section of Pediatric Cardiothoracic Surgery at the School of Medicine.
Fatal cell malfunction ID’d in Huntington’s disease
New research from the School of Medicine’s Albert Kim, MD, PhD (left), and Hiroko Yano, PhD, helps explain how mutations in the gene that causes Huntington’s disease kill brain cells. The findings could open new opportunities for treating the fatal disorder.
How repeatable is evolutionary history?
Some clover species have two forms, one of which releases cyanide to discourage nibbling by snails and insects and the other of which does not. A scientist at Washington University in St. Louis found that this “polymorphism” has evolved independently in six different species of clover, each time by the wholesale deletion of a gene. The clover species are in a sense predisposed to develop this trait, suggesting that evolution is not entirely free form but instead bumps up against constraints.
Barnett appointed chair of Sam Fox School’s landscape architecture program
Internationally acclaimed landscape architect Rod Barnett has been appointed chair of the Master of Landscape Architecture program in the Sam Fox School of Design & Visual Arts. He will join the program Aug. 1.
PARC wins renewed funding for photosynthetic research
The Department of Energy has awarded the Photosynthetic Antenna Research Center (PARC) $14.4 million for continuing research on natural and bio-inspired systems for harvesting the sun’s energy. The center, which is hosted by Washington University in St. Louis, was one of 32 projects selected for funding from among more than 200 proposals and one of only 22 to receive second-round funding.
Crain, Sherraden discuss Economic Fragility in Washington
The Brown School’s Michael Sherraden and the School of Law’s Marion G. Crain, co-authors of the new book “Working and Living in the Shadow of Economic Fragility,” were in Washington, D.C., May 28 at the New America Foundation for a webcast presentation that Crain called “a chance for scholars to talk to the world.” U.S. economic policies have failed to restore full employment and in some ways have made labor market conditions worse for many Americans, they said.
Humans have been changing Chinese environment for 3,000 years
A widespread pattern of human-caused environmental degradation and related flood-mitigation efforts began changing the natural flow of China’s Yellow River nearly 3,000 years ago, setting the stage for massive floods that toppled the Western Han Dynasty, suggests new research from Washington University in St. Louis.
St. Louis Mosaic Project and Washington University to host international student employment workshop
What: Representatives from five universities will gather to discuss ways to prepare international students for the local labor market When: 9:30 a.m. to 1:30 p.m. Tuesday, June 24 Where: Room 103, Siegle Hall, Washington University at St. Louis More info: Betsy Cohen, Project Director, St. Louis Mosaic Project at 314-615-8107 or ecohen@worldtradecenter-stl.com As part of […]
New clues to mortality risk for heart attack patients taking Plavix
School of Medicine researchers have identified the first genetic variations linked to race that begin to explain a higher risk of death among some African American and Caucasian patients taking the anti-clotting drug clopidogrel (Plavix) after a heart attack.
View More Stories